Michael Fugl Hallgren

Largest profit: Novo Nordisk Pharmatech A/S (2017) '103,665 DKK

Most equity: Novo Nordisk Pharmatech A/S (2017) '528,953 DKK

• Novo Nordisk Pharmatech A/S

  Active

  
  

  Board member (2015-01-23 - 2019-01-24)

• GLOBUS V/MICHAEL HALLGREN

  Inactive

  
  

  Legal owner (1999-05-01 - 2000-03-31)

• NNE A/S

  Active

  
  

  Board member (2018-03-01 - present)

• Eastway-Trade I/S

  Inactive

  
  

  Legal owner (2004-10-01 - 2004-11-22)

• ProNelli I/S

  Active

  
  

  Ultimate beneficial owner (2004-10-01 - present) 50% ownership (2004-10-01 – ) 50% voting rights (2004-10-01 – )

  Legal owner (2004-10-01 - present)